Quantcast

Latest Radiofrequency ablation Stories

2014-04-24 08:32:37

Latest Data Sweep from Large Subgroup of Patients Shows a Strong 50% Improvement in Overall Survival for ThermoDox® LAWRENCEVILLE, N.J., April 24, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced that updated results from the 701 patient HEAT Study post-hoc analysis, as well as a review of the final study design of the Phase III OPTIMA Study, which both explore ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin, in...

2014-04-18 16:22:54

- Led by New Enterprise Associates and Experienced Medical Device Industry Veterans, Financing Will Support Development of Next Generation TempaSure(TM) Radiometric Temperature-Sensing Radio-Frequency Ablation Catheter Capable of Accurate, Real-Time Volumetric Temperature Measurement During Irrigated Ablation MENLO PARK, Calif., April 18, 2014 /PRNewswire/ -- Advanced Cardiac Therapeutics, Inc. ("ACT"), a medical device company that is developing a novel, temperature-sensing,...

2014-04-14 12:33:30

Epidemiological, genetic and clinical data presented today at the International Liver CongressTM 2014 are collectively focused on different approaches designed to improve the diagnosis, staging and treatment of hepatocellular carcinoma (HCC). "Human hepatocellular carcinoma is one of the most prevalent cancers worldwide and the second most frequent cause of cancer-related death," said EASL's Scientific Committee Member Dr Helen Reeves Senior Lecturer & Honorary Consultant...

2014-04-11 08:25:08

Company Trademarks Technology As COOLIEF* Cooled Radiofrequency Treatment ROSWELL, Ga., April 11, 2014 /PRNewswire/ -- Kimberly-Clark Health Care today announced the launch of MyCoolief.com, a consumer website designed to provide patients with information about its COOLIEF* Cooled Radiofrequency Treatment, a minimally invasive and non-surgical outpatient procedure used by interventional pain physicians to target the nerves causing chronic back pain in long-term sufferers....

2014-04-10 08:30:03

Professor Riccardo Lencioni is giving an honorary lecture on April 24, 2014 which will highlight the latest findings and lessons learned from the HEAT Study and the design of the Phase III OPTIMA Study LAWRENCEVILLE, N.J., April 10, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that Professor Riccardo Lencioni, MD, FSIR, EBIR, Professor and Director of the Diagnostic Imaging and Intervention at the Pisa University School of Medicine in Italy, former ECIO President,...

2014-03-24 16:23:03

JVIR Editor's Award for Outstanding Clinical Research Paper on Lens Opacities in Catheterization Personnel Presented to International Authority on Radiation Protection; Outstanding Laboratory Investigation Article Examines Therapies That Help Chemotherapy Patients SAN DIEGO, March 24, 2014 /PRNewswire-USNewswire/ -- The Journal of Vascular and Interventional Radiology--the Society of Interventional Radiology's peer-reviewed scientific journal--together with SIR Foundation, will...

2014-02-24 08:28:34

Study Developed in Consultation with Clinical Advisors, Statistical Experts and FDA LAWRENCEVILLE, N.J., Feb. 24, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that the U.S. Food and Drug Administration (FDA) has reviewed and provided clearance for the Company's planned pivotal, double-blind, placebo-controlled Phase III trial of ThermoDox®, its proprietary heat-activated liposomal encapsulation of doxorubicin in combination with radio frequency...

2014-02-19 13:04:18

Among patients with untreated paroxysmal (intermittent) atrial fibrillation (AF), treatment with electrical energy (radiofrequency ablation) resulted in a lower rate of abnormal atrial rhythms and episodes of AF, according to a study in the February 19 issue of JAMA. Arial fibrillation affects approximately 5 million people worldwide and is associated with an increased risk of stroke. Drug treatment is recommended by practice guidelines as a first-line therapy in patients with paroxysmal...

2014-01-29 20:23:35

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/bzzq4x/global) has announced the addition of the "Global Electrophysiology (EP) Devices- Market Growth Analysis" [http://www.researchandmarkets.com/research/bzzq4x/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The broad health care' division has been witnessing a rapid growth and technological improvements...

2014-01-27 08:27:50

Latest Data from Large Subgroup of Patients Shows that the Combination of ThermoDox® and Optimized RFA Provides a Statistically Significant Survival Improvement of Over 50% LAWRENCEVILLE, N.J., Jan. 27, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced that the latest overall survival data from its post-hoc analysis of results from the Company's Phase III HEAT Study of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin in...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related